Seborrheic melanosis has also been discussed as "postinflammatory hyperpigmentation", which may result from any papulosquamous dermatitis affecting the face, including seborrheic dermatitis, acne, atopic dermatitis, perioral dermatitis, psoriasis, allergic contact dermatitis, and angular cheilitis (3)
One patient, Kori P., shared: As soon as I walked in the door I was greeted
article/pii/S0140673624014983 [Additional references continue covering all cited sources from the searches conducted] [1] Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial ScienceDirect science/article/pii/S0140673624014983 [2] The SELECT trial of semaglutide in patients with overweight or obesity without diabetes: establishing a new pathway to secondary prevention of cardiovascular disease PubMed pubmed.ncbi.nlm.nih.gov [3] Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial PubMed pubmed.ncbi.nlm.nih.gov [4] Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial PubMed pubmed.ncbi.nlm.nih.gov [5] GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)
CDIPT also interacts with proteins of numerous HPV serotypes 38,54 , EBV 38 , and HIV-1 55
But the price disparity of GLP-1s has given compounders and telehealth platforms an avenue to openly spar with pharmaceutical giants over affordability, even as industry representatives acknowledge that compounding was never intended to serve as a competitor to Big Pharma
For the compounding pharmacy, this is not without legal risk
